Results 201 to 210 of about 175,700 (308)

Brolucizumab for Wet Aged-Related Macular Degeneration Patients : too Good to be True

Tania Purbonegoro, Mohammad Eko Prayogo, Angela Nurini Agni, Tri Wahyu W., Supanji Supanji, S. W. Firman, Muhammad Bayu Sasongko   +6 more
openalex   +1 more source

Ocular perfusion pressure and choroidal thickness in eyes with polypoidal choroidal vasculopathy, wet-age-related macular degeneration, and normals [PDF]

, 2013
Pukhraj Rishi, Ekta Rishi, G. Mathur, Vishal Raval   +3 more
openalex   +1 more source

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 535-544, February 2026.
Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr, Anette D. Kjeldsen, Annette D. Fialla, Anne‐Emmanuelle Fargeton, Alexandre Guilhem, Elisabetta Buscarini, Freya Droege, Guido Manfredi, Hans‐Jurgen Mager, Jean‐Christophe Saurin, Jens Kjeldsen, Josefien Hessels, Marco C. Post, Robert Mandic, Sanne Boerman, Stefan Kasper‐Virchow, Sören Möller, Urban Geisthoff, Sophie Dupuis‐Girod   +18 more
wiley   +1 more source

A Novel N‐Terminal PRPF6 Variant in Autosomal Dominant Retinitis Pigmentosa

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT This report identifies the first N‐terminal PRPF6 variant (c.514C>T) as a cause of autosomal dominant Retinitis Pigmentosa. This novel variant is associated with progressive peripheral vision loss but notably preserved central visual acuity, suggesting a distinct phenotypic expression compared to C‐terminal variants.
Na Li, Yalong Dang
wiley   +1 more source

Inter-scan repeatability of drusen and geographic atrophy measurements using spectral domain optical coherence tomography in eyes with Age related macular degeneration

, 2017
Jyotsna Maram, Muneeswar Gupta Nittala, Amir H Hariri, SriniVas R. Sadda   +3 more
openalex   +1 more source

Age-related macular degeneration and changes in the extracellular matrix

, 2014
Małgorzata Nita
openalex   +2 more sources

Symptomatic Vulvar Primary Cutaneous Amyloidosis Associated With Low–Risk HPV: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Primary localized cutaneous amyloidosis (PCLA) of the vulva is an infrequent diagnosis. Its clinical presentation may mimic neoplastic or inflammatory lesions and could even be associated with human papillomavirus (HPV) of low or high oncogenic risk, making accurate diagnosis and exclusion of systemic involvement essential. A 73‐year‐old woman
Jorge Hoegl, Andreina Fernandes, Daniel Marquez, Ysleyer Silva   +3 more
wiley   +1 more source

Assessing uptake of the macular degeneration core outcome set in clinical trials: a cross-sectional study. [PDF]

BMJ Open
Oldham E, Hall RH, Jones G, Modi J, Ward S, Magee T, Fitzgerald K, Magana K, Hughes G, Ford AI, Vassar M.   +10 more
europepmc   +1 more source

The Neurotoxic Phenotype of Macrophages from Patients with Age-Related Macular Degeneration (AMD)

, 2019
Itay Chowers, Sarah Hayoun, Batya Rinsky, Shira Hagbi-Levi, Michelle Grunin   +4 more
openalex   +1 more source

Evaluation of New and Established Age-Related Macular Degeneration Susceptibility Genes in the Women's Health Initiative Sight Exam (WHI-SE) Study

, 2011
Inga Peter, Gordon S. Huggins, José M. Ordovás, Mary N. Haan, Johanna M. Seddon   +4 more
openalex   +1 more source